Skip to main content

Table 2 Co-Morbidities of 1,123 Patients Hospitalized With COVID-19

From: COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait

  Kuwaiti (N = 294) Non-Kuwaiti (N = 829) Overall (N = 1123)
Any comorbidity
 At least one comorbidity 140 (47.6%) 214 (25.8%) 354 (31.5%)
 No comorbidities 154 (52.4%) 615 (74.2%) 769 (68.5%)
Hypertension
 No 213 (72.4%) 721 (87.0%) 934 (83.2%)
 Yes 81 (27.6%) 108 (13.0%) 189 (16.8%)
Diabetes
 No 227 (77.2%) 728 (87.8%) 955 (85.0%)
 Yes 67 (22.8%) 101 (12.2%) 168 (15.0%)
Asthma
 No 269 (91.5%) 806 (97.2%) 1075 (95.7%)
 Yes 25 (8.5%) 23 (2.8%) 48 (4.3%)
Total Comorbiditya
 0 154 (52.4%) 615 (74.2%) 769 (68.5%)
 1 55 (18.7%) 132 (15.9%) 187 (16.7%)
 2 38 (12.9%) 57 (6.9%) 95 (8.5%)
 3 30 (10.2%) 19 (2.3%) 49 (4.4%)
 4 14 (4.8%) 6 (0.7%) 20 (1.8%)
 5 2 (0.7%) 0 (0%) 2 (0.2%)
 6 1 (0.3%) 0 (0%) 1 (0.1%)
  1. aComorbidities were diabetes mellitus, hypertension, coronary artery disease/ischemic heart disease, chronic obstructive pulmonary disease, asthma, cerebrovascular disease, hepatitis, dyslipidemia, cancer, hypothyroidism, chronic renal disease, immunodeficiency, recent surgery (during the past 30 days), pregnancy, and other